These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10649706)

  • 1. The rationale for, and role of, heparin in peritoneal dialysis.
    Goel S; Misra M; Saran R; Khanna R
    Adv Perit Dial; 1998; 14():111-5. PubMed ID: 10649706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic effects of heparin and heparinoids in peritoneal dialysis.
    Gozdzikiewicz J; Borawski J; Mysliwiec M
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):92-7. PubMed ID: 18160609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [LMWH and UFH in direct comparison. Consent: CERTIFY].
    MMW Fortschr Med; 2007 May; 149(20):53. PubMed ID: 18051967
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
    Bazargani F
    Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Percutaneous absorption of heparin: a critical review of experimental results].
    Sznitowska M; Janicki S
    Pol Merkur Lekarski; 2000 Jan; 7(43):58-63. PubMed ID: 10765658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
    Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
    Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detrimental effects of acute heparin administration on ischemic threshold in patients with coronary artery disease.
    Fragasso G; Leonardo F; Piatti P; Monti LD; Sheiban I; Gernone F; Setola E; Pontiroli AE; Chierchia SL
    Ital Heart J; 2000 Jun; 1(6):407-11. PubMed ID: 10929741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial antithrombotic effects of aspirin, heparin, enoxaparin and clopidogrel alone, or in combination, in the rat.
    Daykin HJ; Sturgeon SA; Jones C; Wright CE
    Thromb Res; 2006; 118(6):755-62. PubMed ID: 16410020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between intraperitoneal bleeding, adhesions, and peritoneal dialysis catheter failure: a method of prevention.
    Gadallah MF; Torres-Rivera C; Ramdeen G; Myrick S; Habashi S; Andrews G
    Adv Perit Dial; 2001; 17():127-9. PubMed ID: 11510259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inadvertent postdialysis anticoagulation due to heparin line locks.
    Pepper RJ; Gale DP; Wajed J; Bommayya G; Ashby D; McLean A; Laffan M; Maxwell PH
    Hemodial Int; 2007 Oct; 11(4):430-4. PubMed ID: 17922740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term fate of left atrial thrombi and incidence of cerebral embolism under continuous anticoagulation therapy].
    Strach K; Meyer C; Hackenbroch M; Tiemann K; Haase J; Pizulli L; Omran H; Schild H; Sommer T
    Rofo; 2005 Dec; 177(12):1706-12. PubMed ID: 16333795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solute transport across the peritoneal membrane.
    Leypoldt JK
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S84-91. PubMed ID: 11792767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM; Struijk DG; Smit W; Krediet RT
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different anticoagulation strategies in off-pump coronary artery bypass operations: a European survey.
    Englberger L; Streich M; Tevaearai H; Carrel TP
    Interact Cardiovasc Thorac Surg; 2008 May; 7(3):378-82. PubMed ID: 18303040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal dialysis patients with high effluent fibrin degradation products.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2009; 25():41-4. PubMed ID: 19886315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical consequences of heparin-free hemodialysis.
    McGill RL; Blas A; Bialkin S; Sandroni SE; Marcus RJ
    Hemodial Int; 2005 Oct; 9(4):393-8. PubMed ID: 16219060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of heparins in end-stage renal disease.
    Sonawane S; Kasbekar N; Berns JS
    Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
    van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
    Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute peritonitis in a C57BL/6 mouse model of peritoneal dialysis.
    Leypoldt JK; Kamerath CD; Gilson JF
    Adv Perit Dial; 2007; 23():66-70. PubMed ID: 17886606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.